What is EDGe Surgical?
EDGe Surgical specializes in the development and provision of advanced surgical instruments, most notably the EDG Ortho 65mm Spine Awl-in-One Tap. Their innovative product line is engineered to enhance accuracy and minimize infection risks for healthcare professionals, ultimately aiming to improve patient outcomes and reduce overall healthcare expenditures. The company also emphasizes a commitment to decreasing the environmental footprint within the healthcare sector.
How much funding has EDGe Surgical raised?
EDGe Surgical has raised a total of $5.3M across 2 funding rounds:
Series A
$4M
Unspecified
$1.3M
Series A (2018): $4M, investors not publicly disclosed
Unspecified (2025): $1.3M, investors not publicly disclosed
What's next for EDGe Surgical?
The recent major strategic investment suggests EDGe Surgical is poised for significant scaling and market expansion. This capital infusion will likely fuel further research and development into next-generation surgical technologies, enhance manufacturing capabilities, and broaden their distribution network. The company's focus on improving patient care and cost-efficiency positions it for substantial growth in the competitive medical device industry.
See full EDGe Surgical company page
